Finance

Lists
Why is 069620 down 2.39%?
Dive Deeper
069620:KRX
Daewoong Pharma
â‚©106,200.00
-2.39%
(-2,600.00) 1D
Sep 23, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 069620...
Open
â‚©109,600
High
â‚©109,700
Low
â‚©106,000
Mkt. cap
1.23T
Avg. vol.
22.06K
Volume
14.29K
Dividend
0.56%
Quarterly dividend
â‚©150
Ex-dividend date
Dec 27, 2023
P/E ratio
6.25
52-wk high
â‚©199,400
52-wk low
â‚©105,000
EPS
â‚©16,988
Shares outstanding
11.59M
No. of employees
2K
Open
â‚©109,600
High
â‚©109,700
Low
â‚©106,000
Mkt. cap
1.23T
Avg. vol.
22.06K
Volume
14.29K
Dividend
0.56%
Quarterly dividend
â‚©150
Ex-dividend date
Dec 27, 2023
P/E ratio
6.25
52-wk high
â‚©199,400
52-wk low
â‚©105,000
EPS
â‚©16,988
Shares outstanding
11.59M
No. of employees
2K
Profile
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
About Daewoong Pharma
CEOChang-jae Lee | Seongsoo Park
Employees1.89K
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
11.26%
22.62%
6.86%
7.44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps